Showing results (101-110 of 2,396) with videos related to
Sort By:
Pageof 240
Breast Cancer (Tokyo, Japan)|March 16, 2013
An overview of the Japan Breast Cancer Research Group (JBCRG) activitiesShinji Ohno, Katsumasa Kuroi, Masakazu ToiBreast Cancer (Tokyo, Japan)|May 22, 2013
Efficacy, safety, pharmacokinetics and biomarker findings in patients with HER2-positive advanced or metastatic breast cancer treated with lapatinib in combination with capecitabine: results from 51 Japanese patients treated in a clinical studyHiroji Iwata, Hirofumi Fujii, Norikazu Masuda, et al.Breast Cancer (Tokyo, Japan)|January 12, 2013
Comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization in HER2 gene amplification in breast cancerRie Horii, Masaaki Matsuura, Takuji Iwase, et al.Breast Cancer (Tokyo, Japan)|January 23, 2013
Gene delivery of cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1 suppresses proliferation of MCF-7 breast cancer cells in vitroDandan Jiang, Xingang Wang, Xiangping Liu, et al.Breast Cancer (Tokyo, Japan)|January 23, 2013
The discordance between primary breast cancer lesions and pulmonary metastatic lesions in expression of aldehyde dehydrogenase 1-positive cancer cellsTomohiro Nogami, Tadahiko Shien, Takehiro Tanaka, et al.Breast Cancer (Tokyo, Japan)|January 24, 2013
Is evaluation of the presence of prepectoral edema on T2-weighted with fat-suppression 3 T breast MRI a simple and readily available noninvasive technique for estimation of prognosis in patients with breast cancer?Takayoshi Uematsu, Masako Kasami, Junichiro WatanabeBreast Cancer (Tokyo, Japan)|December 26, 2012
Effects of toremifene versus tamoxifen on breast cancer patients: a meta-analysisFeng Chi, Rong Wu, Yuecan Zeng, et al.Breast Cancer (Tokyo, Japan)|April 6, 2012
Prognostic factors for survival after first recurrence in breast cancer: a retrospective analysis of 252 recurrent cases at a single institutionWakako Tsuji, Satoshi Teramukai, Masaya Ueno, et al.Breast Cancer (Tokyo, Japan)|April 6, 2012
Breast biopsy for mammographically detected nonpalpable lesions using a vacuum-assisted biopsy device (Mammotome) and upright-type stereotactic mammography unit without a digital imaging system: experience of 500 biopsiesShozo Ohsumi, Naruto Taira, Daisuke Takabatake, et al.Breast Cancer (Tokyo, Japan)|February 6, 2013
Collapsin response mediator protein 2 is involved in regulating breast cancer progressionKazuhiro Shimada, Takashi Ishikawa, Fumio Nakamura, et al.Pageof 240